Professor of Anesthesia; Assoc. Director of the MGD Centre for Medicinal Cannabis Research; Canada Research Chair in Prevention & Management of Chronic Pain
While fair criticism is welcome and may provide important opportunities to improve or correct publications, erroneous claims offer an opportunity for correction. Our team recently had such opportunity: painphysicianjournal.com/cur…
We found moderate to high certainty evidence that beta-blockers and CGRP-targeted therapies probably reduce migraine frequency. Calcium channel blockers and anticonvulsants may also be effective for reducing migraine frequency but are less well tolerated: ebm.bmj.com/content/early/20…
Our review found low certainty evidence that several interventional procedures for chronic spine pain show risk of deep infection, dural puncture, temporary altered level of consciousness and prolonged pain or stiffness: bmjopen.bmj.com/content/16/6…
Our review found high certainty evidence that 5 in every 100 active-duty Canadian Armed Forces members live with PTSD and moderate certainty evidence that 12 in every 100 Canadian veterans probably live with PTSD:
militaryhealth.bmj.com/conte…
New review out on migraine prophylaxis. Monoclonal antibodies are promising, but trials require replication. Evidence for botulinum toxin, propranolol, topiramate, and valproate was largely at high risk of bias:
acpjournals.org/doi/10.7326/…
Can access to chiropractic care reduce use of opioids for chronic spine pain? Observational data suggests yes, RCTs needed to confirm: journals.lww.com/painrpts/fu…
New Consensus Statement on medical cannabis competencies: jamanetwork.com/journals/jam…
Important start to ensuring clinicians are prepared to support patients who use cannabis.
New trial (nature.com/articles/s41591-0…) confirms the findings of our 2021 review (bmj.com/content/374/bmj.n103…) that found non-inhaled cannabis products may provide important pain relief to a minority (10-15%) of people living with chronic back pain. Long term effects remain uncertain.
💉💊⚕️Michael G. DeGroote National Pain Centre is looking for participants for a qualitative study exploring experiences on opioid tapering to manage chronic non-cancer pain. Sign-up for this opportunity on Pain Connect today: tinyurl.com/2pmt6x9z
Welcome to our Research Spotlight featuring Dr. @JasonWBusse! Learn more about what led him to his current career, and how his research has led to medical and policy developments. Find the interview here: instagram.com/reel/DLpq4casn…
🚨Our systematic review found that almost 50% of women and a third of men exaggerate their symptoms when undergoing Independent Medical Evaluations. Exaggeration ≠ malingering.
Most attendees presented with chronic pain or mild traumatic brain injury: journals.plos.org/plosone/ar…
We found moderate certainty evidence that preserving the intercostal brachial nerve during breast cancer surgery probably protects against chronic post-surgical pain: sciencedirect.com/science/ar…
Our analysis of 906,404 tweets regarding ME/CFS identified frustration with labelling the condition as psychosocial and a desire for identification of physical causation and biomedical treatments.
We also found enthusiasm for the 2021 NICE guidelines that reversed the prior recommendation in favor of graduated exercise therapy, and claims that revisions were the result of patient advocacy efforts: jmir.org/2025/1/e65087/
Our review of 488 randomized trial protocols found that less than half reported their outcomes as originally specified in the corresponding trial publication. This suggests substantial risk for reporting bias: pubmed.ncbi.nlm.nih.gov/4034…
Our survey of total joint arthroplasty patients found that 40% were receptive to opioid-free post-op care, and 50% to reduced opioid use after surgery: cureus.com/articles/323929-p…
We found that medical cannabis as an alternative to opioids for chronic pain may confer similar, but modest, benefits to patients, and reduce the risk of opioid overdose without substantially increasing costs: liebertpub.com/doi/10.1089/c…
Prior reviews report acupuncture is highly effective for diabetic peripheral neuropathy. We found only low or very low certainty evidence, no improvement in function, and that acupuncture provided less pain relief when compared to sham vs. usual care: link.springer.com/article/10…